As shown by immunofluorescence in tumor spheres, TLR3 expression is stronger after the treatment with poly (I:C) and poly (A:U), as well as the expression of CD133, and TLR3 and CD133 co-localize (Figure 2c). The gene discussed is PROM1; the disease is neoplasm.